Attention-deficit hyperactivity disorder (ADHD) is a highly heritable disorder of impaired behavioral inhibition, increased motor activity, and inattention. The norepinephrine transporter (NET, SLC6A2) represents an important candidate gene for contribution to ADHD because it regulates catecholamine extracellular and tissue concentrations and contributes to executive functions disrupted in ADHD, and NET is a target for most effective ADHD therapeutics. We identified four NET coding single nucleotide polymorphisms (SNPs) in two ADHD sample sets; two SNPs produce protein variants (T283M, V245I), one of which, T283M, is a novel variant. Examination of the maternal family members through whom the T283M mutation was transmitted, provided no additional ADHD diagnoses. Given the previous identification of a NET mutation that contributes to a familial tachycardia syndrome, we examined autonomic function to reveal in the proband the highest standing-induced increase in heart rate among the ADHD subjects examined. We measured [ 3 H]NE and [ 3 H]dopamine transport for T283M, V245I, and a previously identified NET variant, T283R. T283M and V245I demonstrated decreased substrate transport, as did T283R, suggesting that the T283 residue is sensitive to mutation. Identification of polymorphic sites within NET, specifically those that produce functional consequences, is one critical step in elucidating the genetic variation contributing to the heritable component of diseases such as ADHD.
Introduction
Attention-Deficit Hyperactivity Disorder (ADHD) is a highly heritable disorder, characterized by impaired behavioral inhibition, increased motor activity, and inattention. Studies of concordance rates for ADHD between monozygotic versus dizygotic twins confirm genetic transmission, with an overall heritability estimate of 76% (Faraone et al., 2005) . Meta-analysis of genome linkage scans reveals chromosomal regions with nominal linkage signals, but no genes have yet been identified via these analyses (Zhou et al., 2008) . Candidate gene studies provide another route for discerning the genes that contribute to ADHD. The role of catecholamines in attention and motor control has focused studies on genes within dopaminergic and, to a lesser extent, noradrenergic systems, including receptors, enzymes involved in synthesis, inactivation and degradation, and regulators of vesicular release (Faraone et al., 2005; Waldman and Gizer, 2006) .
Abnormal regulation of norepinephrine (NE) neurotransmission is hypothesized to contribute to ADHD (Beane and Marrocco, 2004; Pliszka, 2005) . The prefrontal cortex (PFC) is a key anatomical substrate for working memory processes, attention, and organization of plans for behavior (Goldman-Rakic, 1996; Robbins, 1996) and its dysfunction is implicated in ADHD (Sullivan and Brake, 2003; Weinberger et al., 1986) . Both NE and dopamine (DA) play a role in mediating attention and working memory in PFC, following the Yerkes-Dodson law, with an inverted U-shaped plot of level of performance dependent on concentration, predicting that intermediate levels of catecholamine are optimal (Arnsten, 1997; AstonJones et al., 1999) .
NET is an important candidate gene for contributing to ADHD because it is a mediator of both NE and DA reuptake (Gresch et al., 1995; Valentini et al., 2004) , and is a target for nearly all effective ADHD therapeutics. Indeed, in addition to the psychostimulants that target NET and the dopamine transporter, atomoxetine, which selectively targets NET, is also an effective medication for ADHD (Spencer et al., 2002) . Initial studies of NET genetic variation and ADHD reported neither association nor preferential transmission of SNPs in intron 7 (rs3785157), exon 9 (rs5569; the coding SNP 1287 G/A), intron 9 (rs998424), or intron 13 (rs2242447) (Barr et al., 2002; De Luca et al., 2004; McEvoy et al., 2002; Retz et al., 2008) . However, two studies reported association of rs3785157, rs998424 and rs2242447 with ADHD (Bobb et al., 2005; Xu et al., 2005) . Several more recent reports, while not replicating these previous findings, demonstrate preferential transmission of rs3785143 (intron 1) and rs11568324 (intron 5) SNPs (Brookes et al., 2006; Kim et al., 2008; Xu et al., 2008) . A recent study found association of rs3785155 with performance on the continuous performance test (CPT) (Kollins et al., 2008) . Medication response has also been examined in several studies. 1287 G/A has been associated with methylphenidate response on hyperactive-impulsive symptoms (Yang et al., 2004) . Haplotypes comprising regions intron 3 through intron 5 and exons 4-9 have been associated with response to amphetamine and atomoxetine, respectively (Dlugos et al., 2007; Ramoz et al., 2009) .
A complementary approach to association studies with multiple or haplotypic markers is to focus on the evaluation of genetic variation having a functional impact on NET transcription, protein expression or regulation. Approximately 20 single nucleotide polymorphisms resulting in amino acid substitutions have been identified in NET. Our group previously identified a SNP that codes for a nonfunctional NET protein variant, A457P, that contributes to a familial form of a cardiovascular disorder, orthostatic intolerance (Hahn et al., 2003; Shannon et al., 2000) . Other NET protein variants also have striking functional phenotypes, such as insensitivity to protein kinase C, which normally downregulates NET activity (Hahn et al., 2005) . Recently, we identified a common, functional NET SNP (rs28386840) at position À3081 upstream of the transcription initiation site that is associated with Inattentive ADHD and phenotypes in major depression (Hahn et al., 2008; Kim et al., 2006a) . This finding was replicated in a larger, independent sample of ADHD parentoffspring trios and siblings demonstrating preferential transmission of the T allele to affected children with the inattentive subtype of ADHD (Gizer et al., unpublished data) . The sequence in the presence of the minor T allele is an E-box motif that binds members of the SNAIL family of transcription factors, and results in decreased transcriptional activity from NET promoter-reporter constructs (Kim et al., 2006a ). In the current study we examine two ADHD cohorts for NET coding SNPs in an attempt to identify functional protein variants that impact ADHD.
Methods

Subjects
All procedures involving human subject participation were approved by the Vanderbilt University Medical Center Institutional Review Board or the University of Chicago, Children's National Medical Center, and the General Clinical Research Center Advisory Council. The ascertainment of these subject sets has been described previously Stein et al., 2005) . Forty-nine Vanderbilt subjects of the inattentive or combined ADHD subtype were available at the time of the present study. The subjects were collected through the Center for Child Development and Clinical Trials Center at the Vanderbilt University Medical Center. The Kiddie-SADS-Present and Lifetime Version (Kaufman et al., 1997) was administered to determine that DSM-IV criteria were met for ADHD subtype; predominantly inattentive, predominantly hyperactive-impulsive, or combined inattentive and hyperactive-impulsive (Ambrosini, 2000) . History of treatment for ADHD and other major medical conditions and family histories for the presence of other psychiatric and medical conditions were collected. In some cases, the Conner's Adult ADHD rating scale (CAARS-S:L) was administered to adult relatives of children with ADHD to ascertain attention-deficit status (Conners et al., 1998) . For the Vanderbilt sample set, including family members assessed, buccal cells were collected in Mouthwash samples and DNA was isolated using the Puregene Cell and Tissue DNA Isolation kit (Gentra systems, Minneapolis, MN) following the manufacturer's instructions. DNA was stored at À20 C. The University of Chicago cohort consisted of a subset of children who participated in a pharmacogenetic study (the exclusion of several subjects was due to lack of DNA sample) , and several additional subjects, for a total of 42 subjects of either inattentive or combined ADHD subtype. Chicago subjects completed a semistructured diagnostic interview and met DSM-IV criteria for ADHD (Stein et al., 2003) . For the Chicago sample, genomic DNA was extracted from whole blood using a PureGene kit (Gentra systems).
Autonomic function tests
Supine and standing heart rates were measured in a subset of the Vanderbilt ADHD group in the Vanderbilt Clinical Trials Center. Subjects were asked to recline quietly for 5 min prior to assuming a standing position for 5 min. Heart rate was measured at the end of each period. Adult autonomic function tests were performed at the Elliot V. Newman Clinical Research Center at Vanderbilt University. For 3 days before testing, the subject consumed a diet that contained 150 milliEquivalents (mEq) of sodium per day and 70 mEq of potassium per day. The diet was free of caffeinecontaining beverages. Heart rate, blood pressure, and plasma NE, epinephrine and DA were assessed after overnight rest with subject in the supine position and again after the subject had been standing for 30 min. The standing test was performed to assess the hemodynamic and biochemical responses to increased central hypovolemia (accentuated by the gravitational stress). For catecholamine measurements, blood was collected in plastic syringes and immediately transferred to chilled vacuum tubes with EGTA and reduced glutathione (Amersham International PLC) and immediately put on ice. The plasma was separated by refrigerated centrifugation at À4 C and stored at À70 C until the assay. Concentrations of NE, epinephrine and DA were measured by batch alumina extraction, followed by high-performance liquid chromatography for separation with electrochemical detection and quantification.
Genetic analysis of NET
PCR amplification of NET exons
Oligonucleotide primers (Invitrogen, Carlsbad, CA) were designed to amplify exons 1 through 15 of NET. Forward and reverse primers were designed to flank and amplify the coding region and exon/intron junctions (Table 1) . Positions are based on NCBI GenBank/EMBL accession numbers X91117-X91127 and AF061198 as described in Table 1 . Polymerase chain reaction (PCR) was performed using 7.5 pmol of each forward and reverse primer, 7.5 nmol dNTPs (New England Biolabs, Beverly, MA), 2.5 U Amplitaq Gold DNA polymerase (Applied Biosystems, Foster City, CA), 0.25 U pfu Turbo DNA polymerase (Stratagene, La Jolla, CA), and 50 ng of genomic DNA using the following amplification parameters: 95 C for 5 min followed by 30 cycles of 95 C for 30 s, 61 C for 45 s, 72 C for 1 min and a final extension of 72 C for 7 min. PCR products were verified on a 1% agarose gel.
2.3.2. Analysis of PCR products for polymorphic sites using temperature gradient capillary electrophoresis (TGCE)
To produce heteroduplex molecules, PCR products from subject DNA were mixed 1:1 with a reference DNA PCR product of the same amplicon whose sequence matches that of a reference NET sequence (NCBI GenBank accession numbers X91117-X91127, AF061198), and underwent the following protocol: 95 C for 3 min, 95 C for 1 min, À3 C/cycle for 5 cycles, 80 C for 1 min, À1 C/cycle for 30 cycles, 50 C for 20 min, 50 C for 1 min, À1 C/cycle for 5 cycles, 45 C for 1 min, À2 C/cycle for 10 cycles. The heteroduplexed products were then diluted and subjected to TGCE analysis by the Vanderbilt Center for Molecular Neuroscience Neurogenomic Core (REVEALÔ, SpectruMedix, State College, PA) (Li et al., 2002) . Analysis of electropherogram peak profiles between samples and reference DNA was performed using Reveal RevelationÔ software (SpectruMedix, State College, PA). Samples that deviated from the reference DNA profile were sequenced using dideoxynucleotide terminator sequencing (ABI 310, Applied Biosystems, Center for Molecular Neuroscience Neurogenomics Core, Vanderbilt University, Nashville, TN).
Genotyping of the À3081 A/T polymorphism
A restriction fragment length polymorphism assay was used to genotype the À3081 A/T SNP. Primers flanking the polymorphic site were used to amplify a fragment that was then digested with the restriction enzyme Bsr 1. The presence of the A allele results in the Bsr 1 restriction site and digestion of the PCR product into two bands that were resolved on a 3% NuSieve agarose gel (Fisher Scientific, St. Louis, MO).
Plasmid constructs
The expression vector pcDNA3 (Invitrogen, Carlsbad, CA) containing the coding sequence for NET, pcDNA3-hNET, described previously (Hahn et al., 2005) , was used in the construction of the NET nonsynonymous SNPs, V245I, T283M, and T283R. Single-point mutations were generated using the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. The following primers were used: V245I forward, 5 0 -CTG ATG GTC GTC ATC ATC GTC TTG TAT-3 0 , and reverse, 5 0 -ATA CAA GAC GAT GAT GAC GAC CAT CAG-3 0 ; T283M forward, 5 0 -GTC CAT GGC GTC ATG CTG CCC GGA GCC-3 0 and reverse, 5 0 -GGC TCC GGG CAG CAT GAC GCC ATG GAC-3 0 ; T283R forward, 5 0 -GTC CAT GGC GTC AGG CTG CCC GGA GCC-3 0 and reverse, 5 0 -GGC TCC GGG CAG CCT GAC GCC ATG GAC-3 0 . Sequences were confirmed using dideoxynucleotide terminator sequencing (ABI 310, Applied Biosystems, Center for Molecular Neuroscience Neurogenomics Core, Vanderbilt University, Nashville, TN).
Cell culture and transfection
All experiments were performed in transiently transfected Cath.a-differentiated (CAD) cells (American Type Culture Collection, Manassas, VA). CAD cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 8% fetal bovine serum (HyClone Laboratories, Logan, UT), L-Glutamine (2 mM) (Invitrogen), and 100 U/ml penicillin/100 mg/ml streptomycin (Invitrogen) in a humidified incubator at 37 C and 5% CO 2 . One day before transfection, cells were plated in individual wells of 24-well plates at a density of 5 Â 10 4 cells/well. Transfection was performed using FuGene 6 reagent as described by the manufacturer (Roche Applied Science, Indianapolis, IN). All experimental manipulations were begun w24 h after transfection. Observations in all experiments were made using multiple DNA stocks to control for any variability in DNA plasmid preparation.
[ 3 H]NE and [ 3 H]DA transport assays
Transport was assayed essentially as described previously (Hahn et al., 2005) . In brief, cells were washed twice with Krebs-Ringer-HEPES buffer (KRH; 120 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 2.2 mM CaCl 2 , and 10 mM HEPES, pH 7.4) and preincubated with assay buffer (KRH, 10 mM D-glucose, 100 mM ascorbic acid, 100 mM pargyline, and 1 mM tropolone) for 10 min at 37 C, with 1 mM desipramine added to a subset of wells to assess nonspecific accumulation, followed by the addition of radiolabeled substrate for a 10 min transport assay. Saturation kinetics to determine K M and V MAX values were carried out using serial dilutions of NE or DA (100 nM-10 mM) with [ were calculated for data expressed as the percentage inhibition of total uptake versus the log of drug concentration by nonlinear regression analysis according to a singlesite competition model (Prism). One-way ANOVA followed by Dunnett's post-hoc test were used.
Results
Vanderbilt and University of Chicago sample demographics
Two sample sets of ADHD subjects were examined in these studies, one from Vanderbilt University and one from the University of Chicago Stein et al., 2005) . Forty-nine subjects from Vanderbilt and 42 subjects from the University of Chicago were included in the present study. Both populations showed a predominance of male subjects, with 84 and 74% males in the Vanderbilt and Chicago cohorts, respectively. This is consistent with the reported higher incidence of ADHD in males. We examined subjects with either the combined or inattentive subtype of ADHD. Subtype diagnosis was 76% combined and 24% inattentive for the Vanderbilt and 57% combined and 31% inattentive (5 patients were lacking subtype designation) for the Chicago samples, consistent with literature that the combined subtype is the most prevalent. Both samples were also predominantly Caucasian, with 84 and 76% for the Vanderbilt and Chicago group, respectively. We combined the Vanderbilt and Chicago samples for analyses, thus producing similar demographics; the combined sample set was 79% male, 87% white and 67% combined subtype (Table 2) .
Vanderbilt and University of Chicago polymorphism discovery
SNP discovery was performed on DNA isolated from buccal cells using temperature gradient capillary electrophoresis (TGCE) followed by dideoxynucleotide sequencing to determine the identity of polymorphisms. Primers juxtaposed to the exon-intron boundaries were used to identify coding polymorphisms (Table 1) . Four coding region SNPs were identified in the samples (Table 3) . Two were synonymous (rs1805068, rs5569) and two were nonsynonymous (rs1805066, unassigned rs number). Three have been observed in the NET gene previously, whereas one is a novel variant. The novel SNP is nonsynonymous, generating the protein variant T283M, present as a heterozygote present in 1 of 91 subjects. This is the first identification of this variant in an individual. The SNP was identified in exon 5 of the gene by observation of an additional peak on the TCGE chromatogram and sequencing revealed a C to T substitution the converts an ACG to an ATG codon (Fig. 1A, B) . T283M is located in the top of TM5. Rs1805066, or V245I, was present as a heterozygote, in 1 of our 91 samples, for an allele frequency less than 1%, similar to what has been reported for this variant (Stö ber et al., 1996) . V245I is located in TM4 of NET. Rs1805068 was present in 4 of the subjects, all heterozygote, for an allele frequency of 2.2%, similar to that reported (NCBI dbSNP). Of these polymorphisms, rs5569 had a minor allele frequency sufficient to allow statistical analyses (Table 2, 3) . Thus, we examined 1287 G/A (rs5569) for association with ADHD subtype in the combined sample set. Logistic regression analysis revealed no association of genotype with combined versus inattentive ADHD. We also tested if genotype was influenced by race, as SNPs in the NET gene, including 1287 G/A, demonstrate ethnic heterogeneity. Genotype differed by race (p < 0.05). Thus, we reexamined the genotype-subtype interaction in the Caucasian only subgroup, with no significant effects. 
T283M proband and family characterization
We identified a novel, nonsynonymous SNP that results in the T283M variant. The T283M subject is diagnosed with inattentive ADHD and was effectively treated with AdderallÔ at the time of the study. Medical and psychiatric histories and DNA samples were collected from family members of this subject. DNA sequencing revealed that the T283M mutation was inherited through the maternal side, with the mother and maternal grandfather heterozygous carriers of the mutant allele (Fig. 1C) . Although self-report indicated that the maternal grandfather experienced depression and the mother was a poor student, no family members met DSM-IV criteria for psychopathology or were diagnosed with ADHD based on the Conner's Adult ADHD rating scale (CAARS-S:L).
We have previously identified and characterized a NET mutation, A457P, that associates with a familial form of orthostatic intolerance, characterized by an abnormally elevated and sustained heart rate displayed upon standing (Hahn et al., 2003; Shannon et al., 2000) . In order to assess the influence of T283M on tachycardia, we collected supine and standing heart rates following 5 min of standing in a subset of our samples in the Vanderbilt group. Group mean heart rates for supine, standing, and change upon standing were 84.3 þ15.4, 94.4 þ 18.0 and 10.1 þ 16.4 bpm, respectively (Fig. 2) . The T283M proband demonstrated an increase in heart rate upon standing of 49 bpm (Fig. 2) . This change in heart rate was the highest of all subjects and was greater than two standard deviations from the mean. We also administered autonomic function tests to the mother of the proband. We measured heart rate and plasma norepinephrine levels following 30 min of upright posture. In adults, the diagnostic criteria for orthostatic intolerance used at Vanderbilt are a standing heart rate change of greater than 30 bpm and a plasma NE level of greater than 600 pg/ml. The heart rate of the mother increased 26 bpm, whereas her plasma NE levels were elevated to 595 pg/ml, very close to the cutoff for orthostatic intolerance diagnosis. Epinephrine levels were 91 pg/ml. Our group also recently identified a functional promoter SNP, À3081 A/T that associates with ADHD. The T283M proband and family members were assessed for this SNP. All maternal family members were homozygous for the T, minor, allele with the exception of the sibling of the T283M proband, who was heterozygous for this polymorphism (Table 4) .
Functional properties of NET protein variants identified in ADHD
The T283M and V245I mutations were engineered into a plasmid vector and transfected in CAD cells to examine functional properties. Additionally, we generated and characterized T283R, a NET SNP deposited in dbSNP and as yet uncharacterized. We performed transport assays, generating saturation curves with V MAX and K M values for both NE and DA uptake (Fig. 3A, B , Table 5 ). Significant changes were observed for NE transport (F(3,8) ¼ 17.8; p < 0.001). T283R was significantly different from wild-type NET (WT) on post-hoc testing, p < 0.05. Significant changes were also observed for DA transport (F(3,8) ¼ 20.9, p < 0.001. The V MAX for DA transport for V245I, T283M and T283R all differed from WT. There were no significant changes in K M , despite an apparent 2 to 3-fold decrease in K M values for T283R (Table 5) .
Stimulation of PKC via phorbol ester treatment or receptor-mediated activation is well-described to downregulate NET in cell culture and native tissue (Apparsundaram et al., 1998a (Apparsundaram et al., , 1998b Bauman et al., 2000) . Additionally, we have identified NET protein variants that have altered sensitivity to phorbol ester-induced NET down-regulation (Hahn et al., 2005) . Thus, we next measured the response of these variants to PKC-mediated down-regulation, induced by phorbol-12-myristate-13-acetate ({beta}-PMA).
Transfected CAD cells were treated for 10 min with 1-10 mM b-PMA followed by a 10 min incubation with [ 
Discussion
The current study examined coding variation in two sample sets of ADHD patients to identify novel, functional variants that may contribute to ADHD. Examining the phenotypes of individuals and families that bear such mutations can provide invaluable knowledge regarding the physiological processes mediated by NET and the consequences of disrupting such control. Indeed, we previously identified in a family a rare yet functional NET variant that correlated with orthostatic tachycardia and elevated plasma norepinephrine levels (Hahn et al., 2003; Shannon et al., 2000) . Such rare variants with a prominent effect on function of that gene product may in fact, in combination with other variants of large effect, be responsible for complex traits. It has been proposed that a summation of rare variants with low frequency but high penetrance are responsible for common, complex traits, as opposed to the common variantcommon disease model (Bodmer and Bonilla, 2008) . Indeed, candidate gene approaches in the study of phenotypes such as lipid metabolism have revealed rare variants with moderate to large effects that contribute to those traits (Cohen et al., 2004) . A similar A.A., African American. Three subjects had unknown ethnicity and five subjects lacked ADHD subtype diagnosis. point is made by the observation that genome-wide association studies fail to detect most of the heritable factors contributing to complex traits in part because they do not capture information about rare variants (Frazer et al., 2009) . Previous work has demonstrated association of 1287 G/A (rs5569) with ADHD or response to medication. The exon 9 SNP has been associated with methylphenidate response on the hyperactive-impulsive symptoms (Yang, 2004) . Interestingly, the G/ G genotype was also reported to be associated with response to the NET blocker nortriptyline in depressed patients (Kim et al., 2006b) . A number of studies of ADHD and NET association were restricted to the combined subtype or did not perform subtype by genotype analyses. Our previous work indicates an association of À3081 A/T with the inattentive subtype in the Vanderbilt ADHD group and in a large set of ADHD families. Thus, we examined the frequency of 1287 G/A in inattentive versus combined subjects in our sample. It is important to consider that synonymous coding SNPs may be functional through such mechanisms as influencing protein folding during translation (Kimchi-Sarfaty et al., 2007) . We did not observe an association of this SNP with ADHD in the current study, indicating that even when accounting for subtype, there is no association of this SNP with ADHD. However, our small sample size may preclude us from observing effects. The TCGE SNP discovery analysis identified a novel protein variant, T283M, in an ADHD subject and family members. The variant was present in the maternal grandfather and mother, although these family members did not meet criteria for ADHD. The NET variant A457P that contributes to a familial form of tachycardia also diminishes transport, albeit in that case nearly completely. Thus, we reasoned that T283M might also produce a cardiovascular phenotype. The ADHD proband demonstrated a standing-induced heart rate elevation that was higher than all other subjects for which heart rate was measured. Autonomic functions tests demonstrated that the mother had high levels of standing-induced plasma NE. These initial observations suggest cardiovascular phenotypes are present in the T283M family, and analysis of family members under more extensive testing conditions is warranted. Other NET variants identified in cardiovascular phenotypes also demonstrate functional impact, including altered expression, transport and regulation by signal transduction pathways (Hahn et al., 2005) . These findings may have relevance for cardiac side-effects of medications used to treat ADHD. Cardiovascular side-effects of stimulant medications, as well as atomoxetine, have been reported, and although the clinical relevance remains controversial, studies show that a small percentage of ADHD patients demonstrate changes in heart rate and blood pressure that are clinically significant (Vitiello, 2008) . Thus, genetic variation in genes such as NET, that contribute to both central mechanisms of attention and motor activity as well as cardiovascular control, may contribute to increased sensitivity to the cardiovascular side-effects of medication in a subset of patients.
Expression of T283M in cell culture demonstrated decreased transport activity. Our discovery of T283M in an ADHD sample prompted us to examine the function of the T283R variant, demonstrating a decrease in transport of both NE and DA. T283R is a variant identified by the Pharmacogenomics Knowledge Base Consortium at a frequency of 0.42% and was present in an Affymetrix screen. Thus, while falling into the rare mutation category, this variant has been found in more than one individual or family. The sensitivity of T283, which is located in TM5, to both substitutions of methionine and arginine on transport suggest that this residue lies in a region of the transporter important to its function. A high resolution structure of a SLC6 bacterial family member, the leucine transporter from Aquifex aeolicus (LeuT Aa ), was recently achieved (Yamashita et al., 2005) . Whereas TMs 1, 3, 6 and 8 contain residues that are critical to the permeation pathway, TM5, with TM4, forms one of two V-like structures that may act as pincers to facilitate conformational change to open and close a gating mechanism to allow neurotransmitter movement through the pore (Henry et al., 2006) .
The proband, mother and maternal grandfather who carry the T283M allele were all homozygous for the decreased function T allele of the NET À3081 A/T polymorphism (Kim et al., 2006a) . Thus, in addition to a decrease in transporter due to the presence of a protein variant, these individuals are homozygous for a common polymorphism that decreases NET gene transcription. The sibling of the proband who is not diagnosed with ADHD both lacks the T283M variant and is heterozygous for the hypofunctioning À3081 allele. The pedigree shows that the T283M variant is carried on the T allele. This suggests that to the extent that other individuals in the population are identified who harbor this mutation, it will be on the background of this lower functioning NET allele. The presence of multiple, functional NET SNPs in an individual would presumably magnify the consequences to altered NET capacity and noradrenergic system signaling.
The NET variant, V245I, was present in our ADHD sample and this NET variant decreased substrate transport. Stö ber et al. first identified this SNP in 1996 in the first paper to describe NET protein variants, with a reported frequency of 0.43% (Runkel et al., 2000; , 1996) . Consistent with the present findings, characterization of V245I by this group revealed a 50% reduction in V MAX compared to WT (Runkel et al., 2000) . This substitution may appear a conservative one; however, variants identified in the serotonin transporter that substitute either an isoleucine or leucine for the valine at amino acid 425 result in striking altered transporter velocity and kinase/phosphatase regulation and are associated with autism-spectrum disorders (Ozaki et al., 2003; Prasad et al., 2009 ). V245I has been validated by several other large-scale genome SNP discovery efforts. Although not a common SNP by standard definitions, it is present in a proportion of the population, i.e., not a single, familial occurrence. One of the replicated findings for associations of a NET SNP with ADHD is that of rs11568324, located in intron 5. Two groups reported its association, along with rs3785143, with ADHD (Brookes et al., 2006; Kim et al., 2008) . A third replication of the finding for rs11568324 was published, when combining the new subject pool with those of the previous studies (Xu et al., 2008) . V245I, is located approximately 7000 bp from rs11568324 and HapMap data report a D 0 value of 1.0 for this SNP pair, suggesting that there is high linkage disequilibrium (LD) between the two SNPs. If it should be verified that these 2 SNPs are in high LD, it is possible that V245I is the functional SNP that drives the association in these ADHD populations. Although the scope of the current work was to identify and characterize coding variation in NET, even if those variants occur at a low frequency, a much larger sample set could now be used to assess the association of V245I with ADHD. Assembly of a catalogue of functional NET SNPs, both common and rare, will be the first important step in studies that sequence multiple variants in candidate genes for their contribution to complex traits and disease.
The variants characterized in the present study would presumably enhance extracellular NE and DA levels in cortical brain regions. The influence of catecholamine levels on attentional processes and ADHD is complex, working through multiple dopaminergic and noradrenergic receptor subtypes on different target neurons in cortex. The effects of NE and DA on attention and working memory follow the Yerkes-Dodson law, an inverted U-shaped plot of level of performance dependent on concentration, predicting that intermediate levels of catecholamine are optimal (Arnsten, 1997; Aston-Jones et al., 1999) . Indeed, alpha-2 agonists improve working memory in nonhuman primates and alpha-1 agonists impair working memory in monkeys, rats and mice (Arnsten et al., 1999; Franowicz et al., 2002) and D1 agonists can alternately disrupt or enhance performance, depending on prefrontal cortex DA levels at the time of drug administration (Floresco and Phillips, 2001; Phillips et al., 2004) . Additionally, stress disrupts working memory (Arnsten, 2004) , and may be due to elevating the levels of catecholamine into the descending portion of the inverted-U curve of function. Thus, the influence of hypofunctioning transporter variants on ADHD (and other disorders) must be considered in the face of this complex physiology.
